Search research articles
Contact Us
Filters
Showing results (121-130 of 127) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 127 results.
Nature
|
April 19, 2023
PI3Kβ controls immune evasion in PTEN-deficient breast tumours
Johann S Bergholz, Qiwei Wang, Qi Wang, et al.
Cancer Discovery
|
November 14, 2025
PTEN Loss Promotes PI3Kβ Phosphorylation and EPHA2/SRC/p-PI3KβY962 Complex Assembly to Drive Tumorigenesis
Shuang Tang, Qian Zhou, Johann S Bergholz, et al.
Nature Medicine
|
June 9, 2016
Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases
Jing Ni, Shakti H Ramkissoon, Shaozhen Xie, et al.
Cell
|
June 19, 2007
Integrative genomic approaches identify IKBKE as a breast cancer oncogene
Jesse S Boehm, Jean J Zhao, Jun Yao, et al.
Nature
|
November 26, 2010
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Cory M Johannessen, Jesse S Boehm, So Young Kim, et al.
Nature
|
July 24, 2012
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Trevor J Pugh, Shyamal Dilhan Weeraratne, Tenley C Archer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2019
Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial
Patrick Y Wen, Mehdi Touat, Brian M Alexander, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 127) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 127 results.
Nature
|
April 19, 2023
PI3Kβ controls immune evasion in PTEN-deficient breast tumours
Johann S Bergholz, Qiwei Wang, Qi Wang, et al.
Cancer Discovery
|
November 14, 2025
PTEN Loss Promotes PI3Kβ Phosphorylation and EPHA2/SRC/p-PI3KβY962 Complex Assembly to Drive Tumorigenesis
Shuang Tang, Qian Zhou, Johann S Bergholz, et al.
Nature Medicine
|
June 9, 2016
Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases
Jing Ni, Shakti H Ramkissoon, Shaozhen Xie, et al.
Cell
|
June 19, 2007
Integrative genomic approaches identify IKBKE as a breast cancer oncogene
Jesse S Boehm, Jean J Zhao, Jun Yao, et al.
Nature
|
November 26, 2010
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Cory M Johannessen, Jesse S Boehm, So Young Kim, et al.
Nature
|
July 24, 2012
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Trevor J Pugh, Shyamal Dilhan Weeraratne, Tenley C Archer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2019
Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial
Patrick Y Wen, Mehdi Touat, Brian M Alexander, et al.
Page
of 13